Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ALPHE.PA
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Pherecydes Pharma SA
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Biotechnology & Medical Research
- Market cap
- 15.83M
- Ent value
- 20.49M
- Price/Sales
- -
- Price/Book
- 2.10
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -52.27%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
ALPHE.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 2.10 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 7.92M |
| EPS (TTM) | -0.59 |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -5.91M |
| Net income (TTM) | -4.25M |
| EPS (TTM) | -0.59 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.04M |
| Net receivables | 0.00 |
| Total current assets | 3.44M |
| Goodwill | 0.00 |
| Intangible assets | 9.07M |
| Property, plant and equipment | 0.00 |
| Total assets | 13.22M |
| Accounts payable | 1.59M |
| Short/Current long term debt | 2.54M |
| Total current liabilities | 2.62M |
| Total liabilities | 5.69M |
| Shareholder's equity | 7.52M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 0.00 |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | 0.00 |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -56.45% |
| Return on Assets | -32.13% |
| Return on Invested Capital | -42.21% |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| ALPHE.PA | S&P500 | |
| Current price drop from All-time high | -79.80% | -8.65% |
| Highest price drop | -81.72% | -56.47% |
| Date of highest drop | 13 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -47.79% | -11.07% |
| Avg time to new high | 154 days | 12 days |
| Max time to new high | 608 days | 1805 days |
COMPANY DETAILS
Marketcap
15.83M
Marketcap category
Small-cap
Description
Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-staphylococcus aureus for the treatment of bone/joint and diabetic foot ulcer infections; anti-pseudomonas aeruginosa, a phage therapy treatment for respiratory tract infections; and anti-escherichia coli for the treatment of respiratory tract infections. The company was founded in 2006 and is headquartered in Romainville, France. As of June 23, 2023, Pherecydes Pharma Société anonyme operates as a subsidiary of ERYTECH Pharma S.A.. As of June 23, 2023, Pherecydes Pharma Société anonyme operates as a subsidiary of ERYTECH Pharma S.A..
Employees
29
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found